Determination of autoantibody for myelin antigens in the serum of patients HLA-DQB1*0602 with multiple sclerosis;Determinação de autoanticorpos para antígenos da mielina no soro de pacientes HLA-DQB1*0602 com esclerose múltipla

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 4, 2003, Pages 968-973

  Carvalho, Adriana ^a   Sant'anna, Gabriele ^a   Santos, Cláudio Cirne ^a   Frugulhetti, Izabel Palmer ^a   Leon, Soniza Alves ^b   Quírico Santos, Thereza ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Autoimmunity; Demyelination; DQB1*0602; HLA; Multiple sclerosis; Myelin antigens

Indexed keywords

AUTOANTIBODY; ENCEPHALITOGENIC PROTEIN; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID;

ADOLESCENT; ADULT; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DEMYELINATING DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MALE; MULTIPLE SCLEROSIS; TH1 CELL;

EID: 0346258059     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2003000600015     Document Type: Article

References (30)

1. Weiner HL, Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002;420:879-884.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000;343:938-952.
3. Caballero A, Alves-Leon S, Papais-Alvarenga R, et al. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens 1999;54:524-526.
4. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001;81:263.
5. Zipp F, Windermuth C, Pankow H, et al. Multiple sclerosis associated aminoacids of polymorphic regions relevant for HLA binding are confined to HLA-DR2. Hum Immunol 2000;61:1021-1030.
6. Olerup O, Hillert J. HLA class II - associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991;38:1-15.
7. Rezende PA. Aspectos genéticos da esclerose múltipla: I - Estudo em gêmeos. Arq Neuropsiquiatr 1996;54:439-450.
8. Spurkland A, Celius EG, Knutsen I, et al. The HLA - DQ(B1*0102, B1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA - DR (B1*01, B1*1501) heterodimer. Tissue Antigens 1997,50:15-22.
9. Tejada-Simon MV, Hong J, Rivera MV, et al. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in MS and healthy individuals. Eur J Immunol 2001;31:907-917.
10. Correale J, Bassani MM, Molinas MMB. Oligoclonal bands and antibodies responses in multiple sclerosis. J Neurol 2002;249:375-389.
11. Bernard CCA, John TG, Slavin A, et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 1997;75:77-88.
12. Rosbo NK, Ben-Num A. T-cell responses to myelin antigens in MS; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. J Autoimmun 1998;11:287-299.
13. Krogsgaard M, Wucherpfnning KW, Canella B, et al. Visualization of myelin basic protein T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med 2000;191:1395-1412.
14. Poser CM, Paty DN, Scheinberg L, et al. New diagnostic criteria for MS: guidelines for research protocols. Ann Neurol 1983;13:227-231.
15. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
16. Weinshenker BG, Bass B, Rice GPA. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
17. Waksman BH, Porter H, Lees M, et al. A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit. J Exp Med 1954;451-470.
18. Lees M, Chao BH, Lin LH, et al. Amino acid sequence of bovine white matter proteolipid. Arch Biochem Biophys 1983;226:643-656.
19. Sambrook J, Maniatis T, Fritch EF. Molecular cloning: a laboratory manual. 2.Ed. New York: Cold Spring Harbor, 1989:1-9.
20. Olerup O, Aldener A, Fogdell A. HLA - DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-134.
21. Al-Ornaishi J, Bashir R, Gendelman HE. The cellular immunology of multiple sclerosis. J Leukoc Biol 1999;65:444-452.
22. Lindert R, Haase CG, Brehm U, et al. Multiple sclerosis: B and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 1999;122:2089-2099.
23. Haase CG, Linington C. The fine specificity of myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol 2001;114:220-225.
24. Linington C, Bradl M, Lassman H, et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulation mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988;130:443-454.
25. Kroepfl JF, Viise LR, Charron AJ, et al. Investigation of myelin/ oligodendrocyte glycoprotein membrane topology. J Neurochem 1996;67:2219-2222.
26. Hogarth PM. Fc receptors are major mediators of antiboby based inflammation in autoimmunity. Curr Opin Immunol 2002;14:798-802.
27. Compston DAS, Kellar W, Robertson N, et al. Genes susceptibility to multiple sclerosis. Acta Neurol Scand 1995;161(Suppl):43-51.
28. Pouly S, Antel JA. Multiple sclerosis and central nervous system demyelination. J Autoimmun 1999;13:297-306.
29. Serjeantson, SW, Gao X, Hawkins BR, et al. Novel HLA - DR2 - Related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 1992;19:11-19.
30. Dekker JW, Easteal S, Gao X, et al. HLA - DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Catonese patients lacking the high - risk DQB1*0602 allele. Tissue Antigens 1992;41:31-36.